![Hoi-Yoon Jung](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Hoi-Yoon Jung
Director Ejecutivo en NOVMETAPHARMA CO., LTD. .
Cargos activos de Hoi-Yoon Jung
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
NOVMETAPHARMA CO., LTD. | Director/Miembro de la Junta | - | - |
Director Ejecutivo | - | - | |
Director Técnico/Científico/I+D | - | - | |
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - | |
Pohang University of Science & Technology | Corporate Officer/Principal | 01/01/2019 | - |
Historial de carrera de Hoi-Yoon Jung
Formación de Hoi-Yoon Jung.
Handong Global University | Graduate Degree |
Pohang University of Science & Technology | Doctorate Degree |
Estadísticas
Internacional
Corea del Sur | 5 |
Operativa
Director/Board Member | 2 |
Chief Tech/Sci/R&D Officer | 2 |
Chief Executive Officer | 1 |
Sectorial
Health Technology | 3 |
Consumer Services | 3 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
NOVMETAPHARMA CO., LTD. | Health Technology |
Empresas privadas | 1 |
---|---|
NovMetaHealth Co. Ltd.
![]() NovMetaHealth Co. Ltd. Pharmaceuticals: MajorHealth Technology Part of NovMetaPharma Co., Ltd., NovMetaHealth Co. Ltd. develops and manufactures products related to metabolic diseases. The company is based in Seoul, South Korea. The South Korean company was founded in 2016. Seon-Wook Hwang has been the CEO of the company since 2016. NovMetaHealth Co. was acquired by NovMetaPharma Co., Ltd. on March 10, 2022 for $12.61 million. | Health Technology |
- Bolsa de valores
- Insiders
- Hoi-Yoon Jung
- Experiencia